ACAD | ACADIA Pharmaceuticals Inc
Category: Consumer goods
Quick infos Headquarters: San Diego, California, United States Trade prices Volume: Market Cap: 3.46B Prev closed: 48.98 Open: 49.08 High: 49.23 Low: 45.71 52 week low: 30.02 52 week high: 58.72 Dividends: No Dividends Next ER: August 4, 2021 After Market Closes
About the Company Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.
Earnings History Date EPS / Forecast Revenue / Forecast August 4, 2021 -0.27 / -0.3044115.22M / 124.9MMay 5, 2021 -0.42 / -0.5299106.55M / 112.01MFebruary 24, 2021 -0.42 / -0.4736121.01M / 122.76MNovember 4, 2020 -0.54 / -0.3835120.58M / 118.82MBeat! August 5, 2020 -0.27 / -0.44110.1M / 103.41MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Sep 3, 2021 16.78 17.17 17.22
16.70
1.15M -2.27% Sep 2, 2021 17.17 17.55 17.77
17.05
1.35M -2.94% Sep 1, 2021 17.69 17.53 17.87
17.36
904.33K 1.03% Aug 31, 2021 17.51 16.97 17.53
16.93
1.19M 3.18% Aug 30, 2021 16.97 17.22 17.36
16.83
714.39K -0.82% Aug 27, 2021 17.11 16.68 17.38
16.44
1.18M 2.58% Aug 26, 2021 16.68 17.16 17.31
16.63
850.67K -2.91% Aug 25, 2021 17.18 16.90 17.42
16.77
1.08M 1.06% Aug 24, 2021 17.00 17.05 17.07
16.63
971.55K 0% Aug 23, 2021 17.00 16.85 17.12
16.71
1.39M 1.92% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:1993 Employees:490 News
ACADIA Pharma slides after 2021 guidance lagged expectations seekingalpha.com Aug 5, 2021 5:03 am ACADIA Pharma EPS beats by $0.03, misses on revenue; FY21 guidance lowered seekingalpha.com Aug 5, 2021 4:22 am ACADIA Pharma Q2 2021 Earnings Preview seekingalpha.com Aug 4, 2021 5:35 am
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Acadia Pharmaceuticals (ACAD) For Possible Securities Law Violations, Encourages Investors with Losses to Contact Its Attorneys finance.yahoo.com Apr 7, 2021 3:39 pm
ACADIA (ACAD) Gets CRL From FDA for Nuplazid sNDA, Shares Down finance.yahoo.com Apr 7, 2021 9:05 am
Is Acadia a Buy Following the FDAs CRL? J.P. Morgan Says Yes finance.yahoo.com Apr 6, 2021 7:48 pm
Acadia Stock Crashes After FDA Rejects Key Drug Analyst Sees Huge Delay investors.com Apr 6, 2021 4:11 pm Acadia Pharmaceuticals: a Tough Pill to Swallow realmoney.thestreet.com Apr 6, 2021 7:43 am Acadia's pimavanserin meets main goal in late-stage dementia-related psychosis study seekingalpha.com Jul 22, 2021 5:12 am Acadia highlights open-label extension NUPLAZID data in Parkinson’s disease patients seekingalpha.com Jun 3, 2021 9:13 pm Acadia maintains 2021 sales guidance as Q1 net sales rise 18% seekingalpha.com May 6, 2021 5:14 am ACADIA Pharma EPS beats by $0.12, misses on revenue seekingalpha.com May 6, 2021 4:15 am ACADIA Pharma Q1 2021 Earnings Preview seekingalpha.com May 5, 2021 5:35 am Acadia shares yet to reflect Nuplazid’s full potential: Cantor seekingalpha.com Apr 16, 2021 3:09 am JNJ’s COVID-19 vaccine woes to benefit mRNA based developers, Needham sizes up telehealth rivals; and more in today’s analyst action seekingalpha.com Apr 15, 2021 8:56 pm Fibrogen hurt by downgrades, Emergent earns a bull despite vaccine mix-up and more in today’s analyst action seekingalpha.com Apr 7, 2021 8:46 pm ACADIA keeps sliding as analyst calls weigh on the stock seekingalpha.com Apr 6, 2021 11:50 pm Acadia downgraded on Nuplazid CRL, Longboard initiated with a buy, and more in today's analyst action seekingalpha.com Apr 6, 2021 9:21 pm
Acadia Pharmaceuticals: Is Potential Nuplazid Delay A Sign Of Trouble Or An Opportunity? finance.yahoo.com Apr 6, 2021 12:34 pm
FDA Rejects Acadias Supplemental New Drug Application For NUPLAZID; Shares Plunge finance.yahoo.com Apr 6, 2021 11:32 am This company doesn't provide a dividend.
Talk about ACADIA Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis
